Japan Promises More Regulatory Staff For Device Approvals
This article was originally published in PharmAsia News
Executive Summary
Japan's medical device regulatory body says it will hire more premarket review staffers and clarify which types of device changes require approval
You may also be interested in...
Japan May Seek Pricing Data From Other Asian Markets – MHLW Official
It would be difficult for Japan to extrapolate "meaningful" comparisons from planned device pricing surveys in other Asian markets, while the burden on manufacturers would increase substantially, according to Harold Smith, representative director of consulting firm L.E.K./Acumen Japan
Japan Promises To Wipe Application Backlog, Embrace Foreign Data In 2006
Japan vows to eliminate its backlog of device applications by October in a June 29 report on regulatory reform efforts in the U.S. and Japan
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).